US Stock MarketDetailed Quotes

Pharming Group (PHAR)

Watchlist
  • 16.680
  • +0.040+0.24%
Close Apr 24 16:00 ET
  • 16.680
  • 0.0000.00%
Post 20:01 ET
1.18BMarket Cap417.00P/E (TTM)

Pharming Group (PHAR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
26.56%376.13M
14.89%106.5B
29.98%97.29M
25.82%93.22M
42.29%79.09M
21.15%297.2M
114,038.67%92.7B
12.28%74.85M
34.97%74.09M
30.66%55.59M
Operating revenue
26.56%376.13M
14.89%106.5B
29.98%97.29M
25.82%93.22M
42.29%79.09M
21.15%297.2M
114,038.67%92.7B
12.28%74.85M
34.97%74.09M
30.66%55.59M
Cost of revenue
28.53%45.5M
72.95%21.1B
3.70%7.07M
12.42%8.97M
-0.75%8.32M
40.41%35.4M
171,296.46%12.2B
-17.79%6.82M
39.43%7.98M
105.79%8.39M
Gross profit
26.29%330.63M
6.09%85.4B
32.61%90.22M
27.43%84.25M
49.94%70.77M
18.94%261.8M
108,538.44%80.5B
16.56%68.03M
34.45%66.11M
22.71%47.2M
Operating expense
16.68%309.75M
12.86%83.4B
15.09%74.47M
7.28%75.25M
22.46%78.2M
9.52%265.47M
109,999.67%73.9B
13.98%64.7M
6.60%70.15M
21.15%63.86M
Selling and administrative expenses
18.36%117.44M
-0.58%51.3B
16.15%51.08M
6.19%51.55M
25.85%57.06M
13.39%99.22M
169,369.12%51.6B
22.13%43.98M
8.15%48.55M
22.24%45.34M
-Selling and marketing expense
-6.73%6.66M
16.36%31.3B
18.97%34.13M
-5.71%31.05M
14.28%34.57M
4.66%7.14M
34,013.69%26.9B
14.18%28.69M
-2.88%32.93M
11.59%30.25M
-General and administrative expense
20.31%110.78M
-19.03%20B
10.87%16.95M
31.27%20.51M
49.04%22.49M
14.13%92.08M
50,478.48%24.7B
40.47%15.29M
42.23%15.62M
51.16%15.09M
Research and development costs
20.71%100.37M
43.95%32.1B
12.85%23.38M
9.71%23.7M
14.15%21.14M
20.65%83.15M
191,694.96%22.3B
-0.15%20.72M
3.27%21.6M
18.57%18.52M
Depreciation amortization depletion
-1.62%9.21M
----
----
----
----
2.24%9.36M
----
----
----
----
-Depreciation and amortization
-1.62%9.21M
----
----
----
----
2.24%9.36M
----
----
----
----
Other operating expenses
12.20%82.74M
----
----
----
----
-4.01%73.74M
----
----
----
----
Operating profit
669.74%20.88M
-69.70%2B
372.86%15.75M
323.16%9M
55.41%-7.43M
83.56%-3.67M
94,482.98%6.6B
107.67%3.33M
75.75%-4.03M
-16.96%-16.66M
Net non-operating interest income expense
-71.82%-8.74M
-1.4B
-237.09%-7.33M
125.77%519K
-2,115.25%-4.49M
-108.87%-5.09M
0
-215.34%-2.17M
-512.70%-2.01M
108.35%223K
Non-operating interest income
-55.21%2.18M
----
-41.21%485K
-28.37%659K
-66.05%604K
32.62%4.86M
-31.93%1.1M
-56.21%825K
36.09%920K
1,346.34%1.78M
Non-operating interest expense
22.69%10.72M
--1.4B
165.04%7.95M
-99.80%4K
227.63%5.1M
46.50%8.74M
--0
--3M
1,034.48%1.97M
-44.33%1.56M
Total other finance cost
-83.76%196K
----
----
----
----
800.75%1.21M
----
----
----
----
Other net income (expense)
171.81%704K
4,100.00%4.2B
1,117.13%4.33M
-140.79%-2.44M
170.00%133K
-97.96%259K
1,193.49%100M
296.69%356K
-69.34%5.99M
-179.17%-190K
Gain on sale of security
-169.96%-4.88M
----
----
----
----
278.80%6.98M
--1.82M
--21K
----
----
Earnings from equity interest
135.40%623K
----
35.07%-287K
186.29%258K
53.27%-250K
-509.00%-1.76M
-172.78%-484K
8.87%-442K
-130.00%-299K
-57.82%-535K
Special income (charges)
167.36%3.39M
----
----
----
----
-130.25%-5.03M
----
----
----
----
-Less:Impairment of capital assets
-90.23%491K
----
----
----
----
7.81%5.03M
----
----
----
----
-Less:Other special charges
---3.88M
----
----
----
----
----
----
----
----
----
-Gain on sale of business
----
----
----
----
----
--0
----
----
----
----
-Gain on sale of property,plant,equipment
--0
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
2,118.31%1.58M
4,100.00%4.2B
-90.86%71K
102.74%1.85M
11.01%383K
-75.17%71K
543.95%100M
155.59%777K
-95.84%912K
-40.41%345K
Income before tax
251.28%12.85M
-28.36%4.8B
742.67%12.76M
11,898.33%7.08M
29.09%-11.79M
29.30%-8.49M
329,986.76%6.7B
-54.22%1.51M
-101.77%-60K
0.30%-16.62M
Income tax
207.85%10.31M
-113.16%-500M
104.43%5.21M
118.39%2.53M
174.23%3.1M
328.76%3.35M
347,885.35%3.8B
1,722.93%2.55M
-43.98%1.16M
6.49%-4.18M
Net income
121.43%2.54M
82.76%5.3B
829.98%7.55M
473.56%4.55M
-19.60%-14.89M
-12.26%-11.84M
92,959.43%2.9B
-129.85%-1.03M
-192.34%-1.22M
-1.97%-12.45M
Net income continuous Operations
121.43%2.54M
82.76%5.3B
829.98%7.55M
473.56%4.55M
-19.60%-14.89M
-12.26%-11.84M
92,959.43%2.9B
-129.85%-1.03M
-192.34%-1.22M
-1.97%-12.45M
Minority interest income
-313K
0
-144K
-169K
0
0
0
Net income attributable to the parent company
124.08%2.85M
82.76%5.3B
829.98%7.55M
485.39%4.69M
-18.24%-14.72M
-12.26%-11.84M
92,959.43%2.9B
-129.85%-1.03M
-192.34%-1.22M
-1.97%-12.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
124.08%2.85M
82.76%5.3B
829.98%7.55M
485.39%4.69M
-18.24%-14.72M
-12.26%-11.84M
92,959.43%2.9B
-129.85%-1.03M
-192.34%-1.22M
-1.97%-12.45M
Basic earnings per share
122.22%0.04
100.00%0.08
650.00%0.11
0.07
-15.79%-0.22
-12.50%-0.18
180.00%0.04
-140.00%-0.02
0
0.00%-0.19
Diluted earnings per share
122.22%0.04
75.00%0.07
650.00%0.11
0.07
-15.79%-0.22
-12.50%-0.18
180.00%0.04
-140.00%-0.02
0
0.00%-0.19
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 26.56%376.13M14.89%106.5B29.98%97.29M25.82%93.22M42.29%79.09M21.15%297.2M114,038.67%92.7B12.28%74.85M34.97%74.09M30.66%55.59M
Operating revenue 26.56%376.13M14.89%106.5B29.98%97.29M25.82%93.22M42.29%79.09M21.15%297.2M114,038.67%92.7B12.28%74.85M34.97%74.09M30.66%55.59M
Cost of revenue 28.53%45.5M72.95%21.1B3.70%7.07M12.42%8.97M-0.75%8.32M40.41%35.4M171,296.46%12.2B-17.79%6.82M39.43%7.98M105.79%8.39M
Gross profit 26.29%330.63M6.09%85.4B32.61%90.22M27.43%84.25M49.94%70.77M18.94%261.8M108,538.44%80.5B16.56%68.03M34.45%66.11M22.71%47.2M
Operating expense 16.68%309.75M12.86%83.4B15.09%74.47M7.28%75.25M22.46%78.2M9.52%265.47M109,999.67%73.9B13.98%64.7M6.60%70.15M21.15%63.86M
Selling and administrative expenses 18.36%117.44M-0.58%51.3B16.15%51.08M6.19%51.55M25.85%57.06M13.39%99.22M169,369.12%51.6B22.13%43.98M8.15%48.55M22.24%45.34M
-Selling and marketing expense -6.73%6.66M16.36%31.3B18.97%34.13M-5.71%31.05M14.28%34.57M4.66%7.14M34,013.69%26.9B14.18%28.69M-2.88%32.93M11.59%30.25M
-General and administrative expense 20.31%110.78M-19.03%20B10.87%16.95M31.27%20.51M49.04%22.49M14.13%92.08M50,478.48%24.7B40.47%15.29M42.23%15.62M51.16%15.09M
Research and development costs 20.71%100.37M43.95%32.1B12.85%23.38M9.71%23.7M14.15%21.14M20.65%83.15M191,694.96%22.3B-0.15%20.72M3.27%21.6M18.57%18.52M
Depreciation amortization depletion -1.62%9.21M----------------2.24%9.36M----------------
-Depreciation and amortization -1.62%9.21M----------------2.24%9.36M----------------
Other operating expenses 12.20%82.74M-----------------4.01%73.74M----------------
Operating profit 669.74%20.88M-69.70%2B372.86%15.75M323.16%9M55.41%-7.43M83.56%-3.67M94,482.98%6.6B107.67%3.33M75.75%-4.03M-16.96%-16.66M
Net non-operating interest income expense -71.82%-8.74M-1.4B-237.09%-7.33M125.77%519K-2,115.25%-4.49M-108.87%-5.09M0-215.34%-2.17M-512.70%-2.01M108.35%223K
Non-operating interest income -55.21%2.18M-----41.21%485K-28.37%659K-66.05%604K32.62%4.86M-31.93%1.1M-56.21%825K36.09%920K1,346.34%1.78M
Non-operating interest expense 22.69%10.72M--1.4B165.04%7.95M-99.80%4K227.63%5.1M46.50%8.74M--0--3M1,034.48%1.97M-44.33%1.56M
Total other finance cost -83.76%196K----------------800.75%1.21M----------------
Other net income (expense) 171.81%704K4,100.00%4.2B1,117.13%4.33M-140.79%-2.44M170.00%133K-97.96%259K1,193.49%100M296.69%356K-69.34%5.99M-179.17%-190K
Gain on sale of security -169.96%-4.88M----------------278.80%6.98M--1.82M--21K--------
Earnings from equity interest 135.40%623K----35.07%-287K186.29%258K53.27%-250K-509.00%-1.76M-172.78%-484K8.87%-442K-130.00%-299K-57.82%-535K
Special income (charges) 167.36%3.39M-----------------130.25%-5.03M----------------
-Less:Impairment of capital assets -90.23%491K----------------7.81%5.03M----------------
-Less:Other special charges ---3.88M------------------------------------
-Gain on sale of business ----------------------0----------------
-Gain on sale of property,plant,equipment --0------------------0----------------
Other non- operating income (expenses) 2,118.31%1.58M4,100.00%4.2B-90.86%71K102.74%1.85M11.01%383K-75.17%71K543.95%100M155.59%777K-95.84%912K-40.41%345K
Income before tax 251.28%12.85M-28.36%4.8B742.67%12.76M11,898.33%7.08M29.09%-11.79M29.30%-8.49M329,986.76%6.7B-54.22%1.51M-101.77%-60K0.30%-16.62M
Income tax 207.85%10.31M-113.16%-500M104.43%5.21M118.39%2.53M174.23%3.1M328.76%3.35M347,885.35%3.8B1,722.93%2.55M-43.98%1.16M6.49%-4.18M
Net income 121.43%2.54M82.76%5.3B829.98%7.55M473.56%4.55M-19.60%-14.89M-12.26%-11.84M92,959.43%2.9B-129.85%-1.03M-192.34%-1.22M-1.97%-12.45M
Net income continuous Operations 121.43%2.54M82.76%5.3B829.98%7.55M473.56%4.55M-19.60%-14.89M-12.26%-11.84M92,959.43%2.9B-129.85%-1.03M-192.34%-1.22M-1.97%-12.45M
Minority interest income -313K0-144K-169K000
Net income attributable to the parent company 124.08%2.85M82.76%5.3B829.98%7.55M485.39%4.69M-18.24%-14.72M-12.26%-11.84M92,959.43%2.9B-129.85%-1.03M-192.34%-1.22M-1.97%-12.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 124.08%2.85M82.76%5.3B829.98%7.55M485.39%4.69M-18.24%-14.72M-12.26%-11.84M92,959.43%2.9B-129.85%-1.03M-192.34%-1.22M-1.97%-12.45M
Basic earnings per share 122.22%0.04100.00%0.08650.00%0.110.07-15.79%-0.22-12.50%-0.18180.00%0.04-140.00%-0.0200.00%-0.19
Diluted earnings per share 122.22%0.0475.00%0.07650.00%0.110.07-15.79%-0.22-12.50%-0.18180.00%0.04-140.00%-0.0200.00%-0.19
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More